These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35667282)

  • 21. Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients.
    Kizilay Mancini O; Acevedo M; Fazez N; Cuillerier A; Fernandez Ruiz A; Huynh DN; Burelle Y; Ferbeyre G; Baron M; Servant MJ
    Rheumatology (Oxford); 2022 Mar; 61(3):1265-1275. PubMed ID: 34115840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.
    Russo B; Borowczyk J; Boehncke WH; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
    Arthritis Rheumatol; 2021 Jul; 73(7):1311-1317. PubMed ID: 33497035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p.
    Henderson J; Pryzborski S; Stratton R; O'Reilly S
    Exp Dermatol; 2021 Jan; 30(1):162-168. PubMed ID: 32592422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.
    Lonati PA; Brembilla NC; Montanari E; Fontao L; Gabrielli A; Vettori S; Valentini G; Laffitte E; Kaya G; Meroni PL; Chizzolini C
    PLoS One; 2014; 9(8):e105008. PubMed ID: 25136988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts.
    Ikawa T; Ichimura Y; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
    J Invest Dermatol; 2022 Jun; 142(6):1541-1551.e3. PubMed ID: 34838790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
    Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
    Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.
    Lapoirie J; Tran L; Piazza L; Contin-Bordes C; Truchetet ME; Bonnet F
    Sci Rep; 2021 Sep; 11(1):18011. PubMed ID: 34504265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.
    Nikitorowicz-Buniak J; Shiwen X; Denton CP; Abraham D; Stratton R
    J Invest Dermatol; 2014 Nov; 134(11):2693-2702. PubMed ID: 24933320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.
    Tomcik M; Zerr P; Palumbo-Zerr K; Storkanova H; Hulejova H; Spiritovic M; Kodet O; Stork J; Becvar R; Vencovsky J; Pavelka K; Filkova M; Distler JH; Senolt L
    Rheumatology (Oxford); 2015 Dec; 54(12):2273-82. PubMed ID: 26231346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
    Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
    J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement.
    De Luca G; Cavalli G; Campochiaro C; Bruni C; Tomelleri A; Dagna L; Matucci-Cerinic M
    Front Immunol; 2021; 12():653950. PubMed ID: 33833766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-16 expression is increased in the skin and sera of patients with systemic sclerosis.
    Kawabata K; Makino T; Makino K; Kajihara I; Fukushima S; Ihn H
    Rheumatology (Oxford); 2020 Mar; 59(3):519-523. PubMed ID: 31377804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
    Fuschiotti P; Larregina AT; Ho J; Feghali-Bostwick C; Medsger TA
    Arthritis Rheum; 2013 Jan; 65(1):236-46. PubMed ID: 23001877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-36α exerts pro-inflammatory effects in the lungs of mice.
    Ramadas RA; Ewart SL; Iwakura Y; Medoff BD; LeVine AM
    PLoS One; 2012; 7(9):e45784. PubMed ID: 23029241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis.
    Dufour AM; Borowczyk-Michalowska J; Alvarez M; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
    J Invest Dermatol; 2020 Jan; 140(1):103-112.e8. PubMed ID: 31276679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of interleukin 17 and 22 in patients with systemic sclerosis: a single-center cross-sectional study.
    Kardum Ž; Milas-Ahić J; Šahinović I; Masle AM; Uršić D; Kos M
    Rheumatol Int; 2023 Feb; 43(2):345-354. PubMed ID: 36416900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.
    Hügle T; O'Reilly S; Simpson R; Kraaij MD; Bigley V; Collin M; Krippner-Heidenreich A; van Laar JM
    Arthritis Rheum; 2013 Feb; 65(2):481-91. PubMed ID: 23045159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.